MOONFARE
MOONFARE is a Seed, Series C+, buyout, growth-equity, venture-capital and secondary fund in the US, global, europe and asia writing $75K+ checks into AI, Consumer, Fintech, Healthcare, technology, business-services, industrials, growth-equity and venture-capital.
- Stages
- Seed, Series C+, buyout, growth-equity, venture-capital, secondary
- Sectors
- AI, Consumer, Fintech, Healthcare, technology, business-services, industrials, growth-equity, venture-capital
- Check size
- $75K+
- Invests in
- US-wide, global, europe, asia
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $4.13B
Thesis
Their core strategy involves securing allocations in top-tier private equity, venture capital, growth equity, and secondary funds, then offering smaller tranches to their investor base. This approach is driven by the increasing interest in alternative assets, companies staying private longer, and the desire for portfolio diversification and higher returns. Moonfare prioritizes funds with proven track records and experienced managers, with a focus on sectors like technology, financial services, business services, healthcare, consumer, and industrials, including a specific interest in AI and machine learning. They operate globally, with headquarters in Berlin and offices in key financial hubs. Moonfare acts as an intermediary, utilizing feeder fund vehicles and offering proprietary products like co-investments and direct deals. As of mid-2026, their global AUM is approximately $4.13 billion (€3.9 billion). Investment minimums generally start from $75,000 in the US, with an average ticket size around $300,000 for direct private investment funds.
Common questions
Does MOONFARE invest at the Seed stage?
Yes. MOONFARE lists Seed, Series C+, buyout, growth-equity, venture-capital and secondary among the stages it invests in.
What check size does MOONFARE write?
MOONFARE writes $75K+ checks.
Where does MOONFARE invest?
MOONFARE invests in the US, global, europe and asia.